Investment
Features
FeesSafety
Academy
More
Pluang+

Compare LTC Properties Inc (LTC) vs TransMedics Group Inc (TMDX) Price & Performance

LTC Properties IncTrade
TransMedics Group IncTrade

Price performance (Past 24H)

Key statistics

LTC Properties Inc vs TransMedics Group Inc — how do they compare? LTC Properties Inc trades at $41.74 (market cap $2.15B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: TransMedics Group Inc is the larger of the two by market cap, and LTC Properties Inc pays a 5.44% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.

LTCTMDX
Market Cap
$2.15B$2.54B
Sector
Real EstateTechnology
52-Week High
$41.92$150.42
52-Week Low
$33.98$61.99
Enterprise Value
$2.99B$2.94B
Dividend Yield
5.44%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About LTC Properties Inc

LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in healthcare facilities through mortgage loans, property lease transactions, and other investments. LTC generates all of its revenue in the United States. LTC is an active capital provider in the seniors housing and health care real estate industry. The company has been actively engaged with its operating partners to create a growing pipeline of projects. LTC considers merger and acquisition investment as a component of its operational growth strategy.

Read more on LTC

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.

Read more on TMDX